Atlas Trials

A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema

Clinical trial NCT05511038 · COMPLETED

Trial details

NCT number
NCT05511038
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2022-08-26
Primary completion
2024-04-16
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.